Zoekresultaten - You searched for Research

182 results

Helena Biosciences to develop automated blood test for chronic liver disease based on VIB and Ghent University research

Read more

Imec to Honor Samsung’s Dr. Kinam Kim With “Lifetime of Innovation Award”

Read more

ThromboGenics NV : New ThromboGenics Ophthalmic Research Findings Presented at ARVO 2017 Annual Vision Research Meeting in Baltimore

Read more

VIB: A new unexpected key player in melanoma development identified

Read more

VIB: Researchers identify nutrient metabolism that drives breast tumor metastasis

Read more

Tau prevents synaptic transmission at early stage of neurodegeneration

Read more

Scientists give tumor-fighting cells a boost in battling bone marrow cancer

Read more

Unchained Labs acquires Trinean

Read more

Biocartis Group NV: MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Read more

Researchers gain new insights into the formation of non-pathological amyloids

Read more

Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s disease

Read more

Imec Reports Micro-Optomechanical Pressure Sensor Advancing Pressure Monitoring in Biomedical Applications

Read more

Imec Leverages the Power of Silicon Fabrication to Create Innovative Neural Probe Demonstrator with Unprecedented Electrode Density

Read more

Scientists pinpoint surprising origin of melanoma

Read more

Imec Designs and Fabricates World-First Miniature Neural Probe for Simultaneous Recording of Multiple Brain Regions at Neuronal Resolution

Read more

Scientists expose protein responsible for allergic diseases

Read more

REVERSED BREXIT: £250 MILLION FOR BART DE STROOPER'S DEMENTIA RESEARCH

Read more

Researchers discover mechanism behind rapid smell source localization

Read more

500 vacancies in the Flemish biotech sector

Read more

Ablynx & Sanofi enter into a strategic collaboration to develop nanobody product candidates

Read more

MDxHealth Opens New Service and Research Laboratory in The Netherlands

Read more

Count your blessings: Quantitative Microbiome Profiling

Read more

MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Read more

Esperite N.V. with CryoSave contributes to treating a 9 year old child with thalassema major in Switzerland

Read more

Biogazelle offers unique mRNA sequencing on plasma

Read more

ThromboGenics Achieves Important Milestone in the Development of THR-149

Read more

ONTOFORCE and Ghent University launch a new innovative ‘text mining’ project

Read more

MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics

Read more

VIB: Shortage of progranulin is a frequent cause of frontotemporal dementia

Read more

Applied Bioinformatics in Life Sciences (2nd edition)

Read more

SLims by Genohm integrated with Pathomation’s PMA.core

Read more

Mithra & Gynial sign commercialization agreement for MyringTM in Austria

Read more

ThromboGenics NV to present THR-317 Pre-clinical Research Findings

Read more

Mithra Obtains Marketing Authorization for Tibelia® in France

Read more

Mithra Signs Exclusive Agreement for Tibelia® in Canada

Read more

Mithra Receives Orphan Drug Designation from EMA for E4 in Neonatal Encephalopathy

Read more

Cell Death and Immunity in Disease: from molecules to translational medicine

Read more

MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test

Read more

Flanders Vaccine

Read more

Advanced Materials for Biomedical Applications conference

Read more

Visionary seminar: 'Regenerative Medicine: Growing the Future'

Read more

The annual CRIG industrial partnering event

Read more

Biocartis Group NV: Biocartis and A*STAR's ETPL initiate development of breast cancer assay to guide therapy selection

Read more

New ThromboGenics' Ocriplasmin Clinical and Health Economic Data Presented at ASRS 2017 Annual Scientific Meeting in Boston

Read more

Scientists unravel role of glutamine synthetase in the spread of cancer

Read more

ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB

Read more

ThromboGenics Business Update - H1 2017

Read more

ELIXIR Innovation and SME Forum: Data-driven innovation in food, nutrition and the microbiome

Read more

bionection – Partnering Conference for Technology Transfer in Life Sciences

Read more

ThromboGenics announces publication in Experimental Eye Research of preclinical data supporting therapeutic potential of THR-317 in DR

Read more

ONTOFORCE wins the EIT Venture Award 2017

Read more

Newly described process in Parkinson’s protein as a potential new therapy route

Read more

Bridging Preclinical and Clinical Development

Read more

ThromboGenics Business Update - Q3 2017

Read more

flanders.bio provides you with insights in the vibrant life sciences sector

Read more

Biocartis Group NV: Biocartis establishes US subsidiary and appoints US General Manager

Read more

MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence

Read more

VIB and DNAlytics team up to develop non-invasive Colorectal Cancer screening test

Read more

Specialized blood vessels enhance tumor-fighting immunotherapy

Read more

argenx receives first preclinical milestone payment in AbbVie collaboration

Read more

Biocartis Group NV: Biocartis Q1 2017 Business Update

Read more

VIBes in Biosciences - International Symposium for PhD students in Life Sciences

Read more

TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week

Read more

MDxHealth Trading Update: January to April 2017

Read more

Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy

Read more

Pauwels Consulting neemt Vandycke & Partners en Mediconsult over

Read more

TiGenix to present at the Crohn's and Colitis Foundation's Novel Technologies in Inflammatory Bowel Disease workshop in New York

Read more

ThromboGenics Business Update - Q1 2017

Read more

Market of 105 billion euros open to Flemish biotech companies

Read more

Ecosynth moves to new laboratories

Read more

Biocartis Group NV: Biocartis launches CE-marked IVD NRAS test for colorectal cancer

Read more

Bone Therapeutics strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors

Read more

Biocartis wins prestigious Galenus Prize with its Idylla(TM) NRAS-BRAF Mutation Test for colorectal cancer

Read more

International Course: Principles of Biosafety

Read more

TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn’s Disease and Ulcerative Colitis

Read more

Belgium showcases expertise on Immunotherapy at the world’s largest Biotechnology Conference – San Diego, June 19- 23, 2017

Read more

Symposium on Liquid Biopsies & Cancer

Read more

Innovation Platforms & Projects

Read more

BCCM training: New developments in gene and plasmid technology

Read more

RegMed

Read more

Aphea.Bio aims at leading position in next generation agricultural biologicals

Read more

argenx receives second preclinical milestone payment in collaboration with LEO Pharma

Read more

iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region

Read more

Navigation and spatial memory: new brain region identified to be involved

Read more

argenx reports second quarter business update and half-year 2017 financial results

Read more

Ablynx announces 2017 half year results and year-to-date business update

Read more

Genohm at the Global Biobank Week in Stockholm

Read more

Mindbytes expands to North America to develop next generation serious medical games driven by artificial intelligence

Read more

Biocartis Group NV: Idylla(TM) Respiratory (IFV-RSV) Panel receives 510(k) clearance by US FDA

Read more

Genohm announced today the signing of several new clients

Read more

Biocartis announces H1 2017 results

Read more

SelectMDx Outperforms PCA3 Stratifying Men for mpMRI

Read more

TiGenix strengthens US operations with senior appointments

Read more

Bone Therapeutics and Asahi Kasei sign exclusive license agreement for PREOB® in Japan

Read more

ONTOFORCE and akcelis collaborate to create and share infographics

Read more

eTheRNA immunotherapies awarded €1 million grant from Flanders Innovation & Entrepreneurship

Read more

Chemcys 2018

Read more

Dinner with Chef Watson

Read more

Seminar: How Real World Data will change your clinical development to the better

Read more

TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601

Read more

argenx reports third quarter 2017 financial results and provides business update

Read more

International recognition for Dirk Inzé

Read more

MDxHealth Nine Month Trading Update

Read more

Biocartis Group NV: Idylla(TM) Performance Data Presented by US Key Opinion Leaders at Association for Molecular Pathology 2017 Conference

Read more

Ablynx announces results for the first nine months of 2017 and a year-to-date business update

Read more

Mindbytes initiates oncology R&D program focused on patient empowerment and is selected as one of five finalists for Astellas Oncology C3 Prize®

Read more

Celyad Announces Third Quarter 2017 Business Update

Read more

Symposium on Sepsis

Read more

Academia-Industry Connect Meeting: Knowledge Valorisation: Matching science and market needs

Read more

The Future of Health Technology: Lab on Chip & Diagnostics platform meeting

Read more

knowledge for growth 2017

Read more

13th International Conference on Renewable Resources & Biorefineries

Read more

CMAST is stepping into a strategic partnership with FlandersBio

Read more

BioBase4SME Natural Fibertastic Workshop aims to encourage SMEs to apply for fully funded Bio-Innovation Coupons for fibre application testing

Read more

Nieuws van de dag - 25/04/2017

Read more

Argenx launches Phase II study of ARGX-110 as a monotherapy in relapsed/refractory CTCL patients

Read more

Genohm releases the new version v5.4 of SLims

Read more

Celyad initiates second dose escalation in THINK trial in first US patient

Read more

2017 IIBN Forum - Biotechnology: from Innovation to Industrial Production

Read more

At The Forefront Of Plant Research

Read more

Next-Generation Antibodies and Protein Analysis (2nd Edition) - A VIB TOOLS & TECHNOLOGIES CONFERENCE

Read more

Nieuws van de dag- 4/05/2017

Read more

Galapagos presents three posters on filgotinib in Crohn's disease at DDW® 2017

Read more

Member Directory

Read more

FDA grants Fast Track Designation for Celyad’s ischemic heart failure therapy, C-Cure®

Read more

Mithra to Initiate PK Study for Estelle®

Read more

Galapagos NV: Seven abstracts on filgotinib accepted by EULAR 2017

Read more

Nieuws van de dag- 18/05/2017

Read more

Mithra Receives GMP Approval for Myring™ Production

Read more

Cochlear acquires exclusive licence to Artificial Intelligence assistant

Read more

ThromboGenics to Present the Industry Pipeline of DME Treatments

Read more

Bootcamp in Entrepreneurial Innovation in Orphan Diseases

Read more

Daily Newsflash- 14/06/17

Read more

Daily Newsflash- 15/06/2017

Read more

Mithra Successfully Raises €26.1 Million

Read more

Daily Newsflash- 23/06/17

Read more

Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and Asean

Read more

TiGenix announces final equity payment for cardiac platform acquisition

Read more

argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas

Read more

Celyad reports promising early results at first dose level of the solid arm of the THINK trial

Read more

Swissmedic has accepted for review the file on Cx601 for the treatment of Crohn's disease patients

Read more

Ablynx achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc., Kenilworth, New Jersey, USA

Read more

Leadership Seminar: Wednesdays in the Summer: Why DNA and Talent do matter

Read more

Mithra Strengthens E4 Patent Position in Australian Market

Read more

BioInvent and ThromboGenics Amending Long-Standing Monoclonal Antibody Development Agreement

Read more

Mithra Submits Myring™ for European Marketing Approval

Read more

Celyad announces initiation of the SHRINK trial

Read more

Interreg 2 Seas Project DERMA Industrial Matchmaking and Showcase Event

Read more

Mithra: Recruitment Completed in Estelle® Population PK Substudy

Read more

Mithra Announces First Subject Completes Estelle® Phase III Study

Read more

GREEN-CHEM: towards small footprint solutions

Read more

argenx announces publication of preclinical data supporting the therapeutic potential of SIMPLE AntibodyTM ARGX-116

Read more

TiGenix obtains commercial production license for expanded manufacturing facility

Read more

PharmaFluidics appoints Fasha Mahjoor as independent director

Read more

Nordic Life Science Days 2017

Read more

Flanders @ Naturejobs Career Expo - Düsseldorf

Read more

Expertise - FUND

Read more

ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)

Read more

Mithra announces 2017 half year results

Read more

Expertise

Read more

Membership Information

Read more

ThromboGenics Presenting THR-687 Preclinical Data at European Association for Vision and Eye Research (EVER) Meeting

Read more

TiGenix to participate and present at key investor and business development meetings

Read more

ThromboGenics Successfully Introduces New 'Already-Diluted' Formulation of JETREA® (ocriplasmin) in the US

Read more

BioFIT 2017

Read more

Flanders @ BIOJapan 2017: Flemish Life Sciences & Biotech Week

Read more

Key Considerations in Health Care Product Development

Read more

Trainings - CONNECT / EDUCATE

Read more

Mithra’s Marketing Authorization Application for Tibelia® Accepted by Health Canada

Read more

Mithra Announces Completion of Recruitment in Donesta® Phase II Study

Read more

Networking

Read more

flanders.bio's flagship event knowledge for growth 2018

Read more

GAMIAN-Europe & CMAST announce collaborative partnership

Read more

Mithra Completes Recruitment for Estelle® Phase III Study in US and Canada

Read more

Mithra Announces Launch of Warrant Exercise Period

Read more

Press Release - Life Sciences & Biotechnology

Read more

OCTIMET Oncology NV awarded €1.12 million grant from VLAIO

Read more

ThromboGenics Strengthens Leadership Team

Read more

MyCartis appoints Philippe Stas as CEO

Read more

Laborama 2018

Read more

Mithra Announces Positive Outcome of Myring™ Commercial Batch Bioequivalence Study

Read more

flanders.bio - CMAST Partner Day: Realizing Life Science Innovation with Impact

Read more